Journal article

Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies

S Plamondon, SC Ng, MA Kamm

Alimentary Pharmacology and Therapeutics | WILEY | Published : 2007

DOI: 10.1111/j.1365-2036.2006.03239.x

Citation metrics

56Web of Science
58Scopus

Keywords

Alpha
Gastroenterology & Hepatology
Low-Dose Thalidomide
Female
Treatment Outcome
Trial
Maintenance Therapy
Middle Aged
Life Sciences & Biomedicine
Science & Technology
Thalidomide
Humans
Adult
Open-Label
Tumor-Necrosis-Factor
Infliximab
Crohn Disease
Retrospective Studies
Male
Pharmacology & Pharmacy
Anti-Inflammatory Agents, Non-Steroidal
Experience